{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/meibomian-cyst-chalazion/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"0460285c-6b58-5743-a4e7-c0e7b7be9e5b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field f0376212-8d01-4410-9a3d-a7f201899cf8 --><h2>Evidence exclusion criteria</h2><!-- end field f0376212-8d01-4410-9a3d-a7f201899cf8 -->","summary":null,"htmlStringContent":"<!-- begin item f5fac7bf-feb1-46e6-8145-a7f20187a3cf --><!-- begin field 45a147a9-cdd1-401e-aaa6-a7f201899cf8 --><h2>Our policy</h2><!-- end field 45a147a9-cdd1-401e-aaa6-a7f201899cf8 --><!-- begin field 089eb260-d98d-427b-ae26-a7f201899cf8 --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 089eb260-d98d-427b-ae26-a7f201899cf8 --><!-- begin field 5204fd0d-dbc9-4c52-aaa9-a7f201899cf8 --><h2>Standard exclusions for scoping literature:</h2><!-- end field 5204fd0d-dbc9-4c52-aaa9-a7f201899cf8 --><!-- begin field cce0c436-ef2f-4108-9824-a7f201899cf8 --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field cce0c436-ef2f-4108-9824-a7f201899cf8 --><!-- begin field 1d388fb3-d381-4741-9cac-a7f201899cf8 --><h2>Possible exclusions for reviewed literature:</h2><!-- end field 1d388fb3-d381-4741-9cac-a7f201899cf8 --><!-- begin field ee6dd2ab-2533-42fd-b824-a7f201899cf8 --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field ee6dd2ab-2533-42fd-b824-a7f201899cf8 --><!-- end item f5fac7bf-feb1-46e6-8145-a7f20187a3cf -->","topic":{"id":"b8ad70ad-fd63-54ad-95ce-9cb01a976077","topicId":"83b169c9-dca7-4b48-8c2f-5f840191325e","topicName":"Meibomian cyst (chalazion)","slug":"meibomian-cyst-chalazion","lastRevised":"Last revised in August 2020","chapters":[{"id":"ce380c6e-3d94-5ad4-a8b6-9fe46e833a6a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"31b10667-6c79-5777-8a90-23262ca3b05d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"45562bbf-dae7-50e1-982d-169c7e5c5538","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"51d7c48d-7e9b-59e0-9b26-056775bc8460","slug":"changes","fullItemName":"Changes"},{"id":"baa47239-625b-5db6-aae4-00668289dfec","slug":"update","fullItemName":"Update"}]},{"id":"fa120f5b-00af-53fd-9552-689fe5dc905d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"40c525e8-09c0-58c3-aa44-5d21fd56e913","slug":"goals","fullItemName":"Goals"},{"id":"77b51ca3-1111-519c-b74d-cd6f06191e87","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"438e6692-f79d-5661-8c6a-8820daa7481b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4b2c99a6-a203-55cf-9968-1e25119a9a02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dc892b82-91f1-5a2e-b455-3e128b9c7953","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"07c20e54-7eb8-532e-a9b9-8f4932b1eeab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"380aae4d-a20e-5643-8b48-5841b3d1eb26","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"70db5497-1bf4-5e7f-9049-2cc54bb758c1","slug":"definition","fullItemName":"Definition"},{"id":"f4fa1377-fc7b-5d61-9c81-12b9a566c573","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8be72264-aa79-5dfc-b028-5e4ec3d4a130","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"75ef5189-b75a-582c-a171-a591d8b4a22b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"1100f706-7196-56a3-8f7b-08f8fb708eaa","slug":"complications","fullItemName":"Complications"}]},{"id":"09b5aa35-8ce9-5ef0-ad8c-8a271452dbcb","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"f6e6a824-264a-52f6-9745-8346a1de5019","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"5da4268d-1aed-5614-bcff-2c4e7c7ef0ae","fullItemName":"Management","slug":"management","subChapters":[{"id":"828f7d50-efa1-585d-aebe-1f64052007aa","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"90dde465-544a-5aa5-8a28-7a884db8e28c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"dcf4042f-9b4d-522d-88ff-e660b5be6702","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d221ae7c-d731-5874-a2c3-55710d9f3579","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4bf0f9c5-61cf-5b7b-815b-1607ee9da389","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0460285c-6b58-5743-a4e7-c0e7b7be9e5b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd31369e-2482-5af3-8f7d-2036152bf417","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5899d820-151b-5e22-b6f1-a318f70a0565","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fc2e5a3f-abe6-572f-91b0-fc070b08be31","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"dcf4042f-9b4d-522d-88ff-e660b5be6702","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}